Gaush Meditech Ltd (HKG:2407)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.12
+0.22 (4.49%)
Jul 31, 2026, 3:37 PM HKT

Gaush Meditech Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,3801,3801,4281,4061,2541,298
Revenue Growth
-4.11%-3.36%1.58%12.16%-3.42%34.94%
Gross Profit
624.87624.87653.96684.6621.25601.61
Operating Income
112.61112.61194.55253.3227.03243.32
Net Income
96.1996.1992.39173.52-349.62-190.45
Earnings Per Share
0.660.660.631.17-3.61-1.99
EPS Growth
-4.48%6.05%-46.68%---

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Distribution Products
697.6697.6819.32808.91744.81810.99
Proprietary Products
561.17561.17525.15532.21389.05391.67
Others
14.9214.926.810.4311.0918.41
Technical Services
238.47238.47226.46209.23190.08161.61
Intersegment Sales
-131.81-131.81-149.34-154.54-81.25-84.45
Total
1,3801,3801,4281,4061,2541,298

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
437.66437.66518.99832.97814.16609
Total Debt
507.15507.15552.24664.367562,622
Net Cash (Debt)
-69.49-69.49-33.24168.6158.16-2,013
Net Cash Growth
---189.92%--
Net Cash Per Share
-0.48-0.48-0.221.140.60-21.00

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
144.23144.23107.78249.04234.42164.49
Capital Expenditures
-22.77-22.77-14.67-34.92-45.4-26.55
Free Cash Flow
121.46121.4693.12214.11189.03137.94
Free Cash Flow Growth
-2.95%30.44%-56.51%13.27%37.04%7.57%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
45.27%45.27%45.78%48.68%49.55%46.34%
Operating Margin
8.16%8.16%13.62%18.01%18.11%18.74%
Pretax Margin
8.31%8.31%10.87%17.62%-21.94%-10.63%
Profit Margin
6.97%6.97%6.47%12.34%-27.88%-14.67%
FCF Margin
8.80%8.80%6.52%15.23%15.08%10.63%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingAug '26 Dec '25 Dec '24 Dec '23
Dividend Per Share
0.300-0.2820.998
Dividend Per Share Growth
0%--71.77%-
Dividend Yield
5.86%-3.19%3.31%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
6.9411.1914.7929.26--
Forward PE
-15.0915.0920.04--
P/FCF Ratio
5.438.8614.6723.7135.69-
PS Ratio
0.480.780.963.615.38-